<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd">
<ArticleSet>
	<Article>
		<Journal>
			<PublisherName/>
			<JournalTitle>IJOTM</JournalTitle>
			<Issn>2008-6490</Issn>
			<Volume>7</Volume>
			<Issue>3</Issue>
			<PubDate PubStatus="epublish">
				<Year>2016</Year>
				<Month>07</Month>
				<Day>1</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Correlation between CMV Infection and Posttransplantation New-onset Diabetes Mellitus</ArticleTitle>
		<FirstPage>173</FirstPage>
		<LastPage>182</LastPage>
		<Language>EN</Language>
		<AuthorList>
			<Author>
				<FirstName>I</FirstName>
				<LastName>Dedinská</LastName>
			</Author>
			<Author>
				<FirstName>Ľ</FirstName>
				<LastName>Laca</LastName>
			</Author>
			<Author>
				<FirstName>J</FirstName>
				<LastName>Miklušica</LastName>
				<Affiliation>Surgery Clinic and Transplant Center, University Hospital Martin and Jessenius Faculty of Medicine, Comenius University, Martin, Slovak Republic. miklusica@unm.sk</Affiliation>
			</Author>
			<Author>
				<FirstName>D</FirstName>
				<LastName>Kantárová</LastName>
			</Author>
			<Author>
				<FirstName>P</FirstName>
				<LastName>Galajda</LastName>
			</Author>
			<Author>
				<FirstName>M</FirstName>
				<LastName>Mokáň</LastName>
			</Author>
		</AuthorList>
		<History>
			<PubDate PubStatus="received">
				<Year>2015</Year>
				<Month>12</Month>
				<Day>16</Day>
			</PubDate>
			<PubDate PubStatus="revised">
				<Year>2016</Year>
				<Month>03</Month>
				<Day>16</Day>
			</PubDate>
		</History>
		<Abstract>Background: New-onset diabetes mellitus after transplantation (NODAT) is a well-known complication of transplantation.Objective: To determine the correlation between CMV infection and NODAT.Methods: Retrospectively, we detected CMV replication (PCR) in every month after renal transplantation in the first 12 months of the procedure in a homogenous group of patients from the immunosuppression point of view.Results: In 167 patients (64 with NODAT and 103 in the control group), the average amount of CMV viremia was not significantly different between the NODAT and the control group (p=0.929). In the 10th month of transplantation, we recorded a significantly higher CMV viremia in the NODAT group (p&amp;lt;0.0001), however, in the multivariant analysis, the observed statistical difference vanished. The survival of patients and grafts was 12 months after kidney transplantation without any statistically significant difference between the studied groups (p=0.611 and p=0.538, respectively). Conclusion: CMV is not a risk factor for NODAT.</Abstract>
	</Article>
</ArticleSet>
